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Background: The restoration of damaged meniscus has always been a challenge due to its limited healing capacity.
Recently, bone marrow-derived mesenchymal stem cells (BMSCs) provide a promising alternative to repair meniscal
defects. However, BMSCs are not ideal chondroprogenitor cells for meniscus repair because they have a high
propensity for cartilage hypertrophy and bone formation. Our hypothesis is that mesenchymal stem cells (MSCs)
reside in meniscus maintain specific traits distinct from others which may be more conducive to meniscus regeneration.
Methods: MSCs were isolated from bone marrow and menisci of the rabbits. The similarities and differences between
BMSCs and MMSCs were investigated in vitro by a cell culture model, ex vivo by a rabbit meniscus defect model and
in vivo by a nude rat implantation model using histochemistry, immunocytochemistry, qRT-PCR and western blotting.
Results: Our data showed that two types of MSCs have universal stem cell characteristics including clonogenicity,
multi-potency and self-renewal capacity. They both express stem cell markers including SSEA-4, Nanog, nucleostemin,
strol-1, CD44 and CD90.
However, MMSCs differed from BMSCs. MMSC colonies were much smaller and grew more slowly than BMSC colonies.
Moreover, fewer MMSCs expressed CD34 than BMSCs. Finally, MMSCs always appeared a pronounced tendency to
chondrogenic differentiation while BMSCs exhibited significantly greater osteogenic potential, whatever in vitro and
in vivo.
Conclusions: This study shows the similarities and differences between MMSCs and BMSCs for the first time. MMSCs
are a promising source of mesenchymal stem cells in repairing meniscus defect.
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The knee meniscus which consists of two semilunar,
wedge-shaped pieces fixed between femoral condyle and
tibial plateau plays a crucial role in the function of knee
joint. Injury or loss of meniscus can lead to osteoarthritis
and irreversible joint damage [1]. Several studies showed
that even partial meniscectomy can significantly increase
the incidence of osteoarthritis [2]. At present, there is an
ever increasing emphasis on meniscus preservation through
surgical repair [3].
Unfortunately, because the meniscus is not a homoge-
neous tissue, capability of self-healing in vascular or avas-
cular part is much different. While tears that occur in the
outer periphery of the tissue can regenerate due to the
high degree of vasculature there, damage to the inner
non-vascularized portion of the tissue is difficult to heal
on its own [4]. Even repaired with different kinds of new
techniques, healing response in avascular zone of me-
niscus was still absent [5]. The successful surgical restor-
ation of the damaged meniscus still remains an ongoing
challenge.
Recently, meniscal regeneration using mesenchymal stem
cells (MSCs)-based tissue engineering techniques have been
attempted, which provide a promising alternative for repair
of meniscal defects [6]. In both clinical and experimental
perspectives, MSCs have received the most attention
due to their multi-differentiation potential. Although ever-
increasing amount of literature has shown that different
kinds of MSCs, including bone marrow-derived MSCs
(BMSCs), synovium-derived MSCs (SMSCs) and adipose-
derived MSCs (AMSCs) may all prove beneficial for me-
niscus repair due to their evident chondrogenic capacity
[7-10], none of them has received a general consensus in
literature. Indeed, the search for effective therapies based
on tissue engineering approaches is still a debated and
investigational issue. The key is to find a kind of novel
MSCs which will satisfactorily integrate with the host,
and which will allow the long-term preservation of cell
viability.
Based on the previous studies, we hypothesize that MSCs
may reside in meniscus, and those meniscus-derived MSCs
(MMSCs) should maintain specific traits distinct from
other MSCs which may improve meniscus regeneration.
However, knowledge of MMSCs still remains limited, and
no studies to date have evaluated their effect on the regen-
eration of meniscus in vivo through compared to BMSCs.
To test our hypothesis, we (1) isolated the MMSCs and
BMSCs from the same rabbit and demonstrated that
MMSCs possessed features typical of stem cells, (2) evalu-
ated their respective multi-differentiative potential in vitro,
(3) detected their regenerative capacity when seeded in the
defect of wounded meniscus within the rabbit model, and
(4) investigated their effect of multi differentiation after
their implantation into the back of nude rats.Methods
Isolation of meniscus-derived mesenchymal stem cells
(MMSCs) and bone marrow stem cells (BMSCs)
Ten female New Zealand white rabbits (8–10 week-old,
3.0 - 4.0 kg) were used in all experiments. The protocol
for use of the animals was approved by the IACUC of
the Nanjing Medical University. The rabbits were fully se-
dated by intra-muscular injection of Ketamine (10 mg/kg)
and Xylazine (3 mg/kg) and were then sacrificed using
pentobarbital (120 mg/kg). After sacrifice, rabbit medial
and lateral menisci were dissected from bilateral knee
joints. For isolation of MMSCs, the parameniscus tis-
sues were removed, and the whole meniscus was then
weighed and minced into small pieces (1 mm × 1 mm ×
1 mm). Each 100 mg tissue sample was digested with
3 mg collagenase type I (Worthington Biochemical Cor-
poration, Lakewood, NJ) and 4 mg dispase (StemCell tech-
nologies Inc., Vancouver, BC, Canada) in 1 ml phosphate
buffered saline (PBS) at 37 °C for 1 hr. The suspensions
were centrifuged at 1,500 g for 15 min, and the super-
natant was discarded. The remaining cell pellet was re-
suspended in growth medium consisting of Dulbecco’s
modified Eagle’s medium (DMEM; Lonza, Walkersville, MD)
supplemented with 20% fetal bovine serum (FBS; Atlanta
Biologicals, Lawrenceville, GA), 100 μM 2-mercaptoethanol
(Sigma-Aldrich, http://www.sigmaaldrich.com), 100 U/ml
penicillin and 100 μg/ml streptomycin (Atlanta Biologicals,
Lawrenceville, GA) to make a single-cell suspension. It was
then cultured in either tissue culture flasks or plates at 37 °C
with 5% CO2.
For BMSCs, two milliliters of bone marrow was aspi-
rated with an 18-gauge needle that was fastened to a 5-ml
syringe containing 0.2 ml of heparin (1,000 units/ml). The
aspirates were washed twice with phosphate-buffered
saline (PBS) and centrifuged at 1,500 rpm for 5 min.
The supernatant was discarded. The cells were re-suspended
in growth medium and incubated in either tissue culture
flasks or plates at 37 °C in a humidified 5% CO2–95% air at-
mosphere. The cell colonies were stained with methyl violet
(Sigma-Aldrich, http://www.sigmaaldrich.com). Colony
numbers were counted manually. Each colony was tryp-
sinized locally under microscopic visualization in order
to detach stem cell colonies and detached cells were
collected.
The total cell numbers from each colony were counted
using a hemocytometer and transferred to T25 flasks for
further culture.Expression of stem cell markers of MMSCs and BMSCs
Immunocytochemistry was used to assay for expression
of the following stem cell markers: nucleostemin, Nanog,
SSEA-4, CD34, CD44, CD90 and STRO-1. To perform
immunostaining, MMSCs and BMSCs at passage 1 were
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and cultured with growth medium for three days.
After removing the medium, the cells were washed with
PBS once. MMSCs and BMSCs were fixed with 4% para-
formaldehyde in PBS for 30 min at room temperature and
treated with 0.1% Triton X-100 for 30 min for Nanog and
nucleostemin staining. After washing the cells with PBS,
either mouse anti-Nanog (1:350, Santa Cruz Biotechnol-
ogy, Inc., cat. # SC-33759, Santa Cruz, CA) or goat anti-
nucleostemin (1:400, Neuromics, Cat. # GT15050, Edina,
MN) was applied to the cells. In order to stain for SSEA-4
and strol-1, fixed cells were incubated either with mouse
anti- SSEA-4 antibody (1:500, Invitrogen, Cat. # 414000,
Frederick, MD), or mouse anti-strol-1 antibody (1:400,
Cat. #398401, Invitrogen, Carlsbas, CA). After 2 hours
reaction at room temperature, the cells were washed
with PBS for three times, and either Cy-3-conjugated
goat anti-mouse IgG antibody (1:500 for Nanog, SSEA-4
and strol-1, Millipore, Cat. # AP124C, Billerica MA) or
Cy3-conjugated donkey anti-goat IgG antibody (1:500 for
nucleostemin, Millipore, Cat. # AP180C, Billerica, MA)
was applied for 1 h at room temperature.
In addition, stem cell surface markers CD34, CD44 and
CD90 were stained in parallel by immunocytochemistry.
Briefly, fixed cells were incubated with fluorescein iso-
thiocyanate (FITC)-conjugated mouse anti-CD34, or FITC-
conjugated mouse anti-CD44, or phycoerythrin (PE)-
conjugated mouse anti-CD90 antibodies (1:400) at room
temperature for 1 hour. Antibodies were purchased from
BD Pharmingen (BD Biosciences; http://bdbiosciences.
com), Stem cell Technologies (Vancouver, BC) and Santa
Cruz Biotechnology (Santa Cruz, CA), respectively.
Fluorescent images of the stained cells were taken by a
CCD camera on an inverted fluorescent microscope
(Nikon eclipse, TE2000-U) using SPOT™ imaging soft-
ware (Diagnostic Instruments Inc., Sterling Heights, MI).
A total of 36 views from 3 wells of a 12-well plate were
randomly chosen for each stem cell marker and the num-
ber of positively stained cells was manually counted. The
percentage of each stem cell marker expression was deter-
mined by dividing the number of positively stained cells
by the total number of cells stained by the nuclear staining
reagent Hoechst fluorochrome 33342 (1 μg/ml; Sigma, St.
Louis, MO).
Multi-differentiation potential of MMSCs and BMSCs in Vitro
Multi-differentiation potential of MMSCs and BMSCs
in vitro were tested for adipogenesis, chondrogenesis,
and osteogenesis. Both types of cells at passage 2 were
seeded either on plastic surfaces in 6-well plates at a
density of 2.4 × 105 cells/well or in 24-well plates at a
density of 6 × 104 cells/well in basic growth medium
consisting of low glucose DMEM, 10% heat inactivated
FBS, 100U/ml penicillin, and 100 μg/ml streptomycin.To test adipogenic potential, cells were cultured in adi-
pogenic induction medium (Millipore, Billerica, MA)
consisting of basic growth medium added with dexametha-
sone (1 μM), insulin (10 μg/ml), indomethacin (100 μM),
and isobutylmethylxanthine (0.5 mM). As a test of
chondrogenic potential, two kinds of MSCs were cultured
in basic growth medium supplemented with prolin
(40 μg/ml), dexamethasone (39 ng/ml), TGF-β3 (10 ng/ml),
ascorbate 2-phosphate (50 μg/ml), sodium pyruvate
(100 μg/ml), and insulin transferrin-selenious acid mix
(50 mg/ml) (BD Bioscience, Bedford, MA). Finally, the
osteogenic potential of MMSCs and BMSCs was tested
by culturing them in osteogenic induction medium
(Millipore, Billerica, MA) consisting of basic growth
medium supplemented with dexamethasone (0.1 μM),
ascorbic 2-phosphate (0.2 mM), and glycerol 2-phosphate
(10 mM).
Histochemical analysis
After culturing for 21 days, MMSCs and BMSCs grown
in 24-well with various differentiation media were stained
using Oil Red O for adipogenesis, Safranin O for chondro-
genesis, or Alizarin Red S for osteogenesis, respectively.
The stained samples were examined using an inverted
microscope as we depicted above. The ratio of positive
staining was calculated by dividing the stained area by
the view area. The values of all views from three dupli-
cate wells were averaged to obtain the percentage of
positive staining, which represents the extent of cell dif-
ferentiation in the respective induction medium.
Quantitative real-time PCR (qRT-PCR)
The specific gene expression of differentiated MMSCs
and BMSCs were determined using qRT-PCR. Total RNA
was extracted using a RNasy Mini-Kit with an on-column
DNase I digest (Qiagen). First-strand cDNA was synthe-
sized in a 20 μl reaction of 1 μg total RNA through reverse
transcription with Super-Script II (Invitrogen). The condi-
tions for the cDNA synthesis were: 65 °C for 5 min and
cooling for 1 min at 4 °C, then 42 °C for 50 min, and fi-
nally 72 °C for 15 min. The qRTPCR was carried out
using QIAGEN QuantiTect SYBR Green PCR Kit (Qiagen)
[11]. In a 25 μl PCR reaction mixture, 2 μl cDNA (total
100 ng RNA) were amplified in a Chromo 4 Detector
(MJ Research). Rabbit-specific primers for differenti-
ated cells were used for collagen type II, peroxisome
proliferators-activated receptor γ (PPARγ), Sox9, osteocal-
cin, and Runx2. Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was used as an internal control. The
forward and reverse primer sequences and the resultant
products were designed according to published methods,
and are listed in Additional file 1: Table S1 [12-15]. All
primers were synthesized by Invitrogen (Carlsbad, CA).
The relative gene expression levels were calculated from
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(CTtarget -CTGAPDH)differentiation-(CTtarget -CTGAPDH)control.
In the formula, CTtarget and CTGAPDH are the cycle thresh-
olds of target gene and GAPDH gene, respectively, for each
RNA sample. The standard deviation (SD) of the ΔCT was
determined from at least three parallel tests.Western blot
Two kinds of MSCs were seeded in 6-well plates at a
density of 2.4 × 105 per well and cultured with adipogenic,
osteogenic and chondrogenic induction media for 21 days,
respectively. Then MMSCs and BMSCs were lysed using
a mammalian protein extraction reagent cocktail (Pierce,
Rockford, Illinois) containing 1.5% protease inhibitors
(Sigma-Aldrich). After centrifugation at 12,000 rpm for
10 minutes, the protein concentrations of the superna-
tants were determined using a BCA Protein Assay kit
(Pierce). Equal amounts of total protein were run on
12% SDS polyacrylamide gels (Bio-Rad) at a constant
voltage of 100 V for 60 minutes. Proteins were blotted
to a nitrocellulose membrane using a Semi-Dry transfer
module (Bio-Rad) at 200 mA for 90 minutes. The mem-
brane was blocked in a 5% dry milk/TBS-Tween 20 so-
lution for 1 hour at room temperature and then probed
for 5 hours with a mouse monoclonal anti-adiponectin
antibody (Millipore; Cat #MAB3604) at a dilution of
1:1000; mouse monoclonal anti-osteocalcin (Abcam;
Cat #ab13418) at a dilution of 1:1000 for 5 hours; and
mouse anti-collagen II (Millipore; Cat # MAB8887) at a
dilution of 1:500 in a 1% dry milk/PBS-Tween 20 solution.
Incubation with the primary antibody was followed by a
horseradish peroxidase-conjugated goat anti-mouse anti-
body (Millipore; Cat #12-349) at a dilution of 1:2000 in a
1% dry milk/PBS solution. The targeted protein bands
were detected using an ECL (enhanced luminol-based
chemiluminescence) detection kit (Amersham Biosciences,
Piscataway, New Jersey), followed by exposure of the
membrane to X-ray film. Membranes were also re-probed
for mouse anti-glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH, EMD Millipore, Merck KGaA, Darmstadt,
Germany; Cat # MAB374) to verify equal protein loading
in the gels. The band intensity was quantified by image J
software (http://rsb.info.nih.gov/nih-image/).Histochemical analysis of wounded meniscus sections
The menisci were obtained aseptically from female New
Zealand white rabbits within 12 hours of death. A wound
with 1 mm diameter was created in the center of each
meniscus by a biopsy punch (Miltex, Inc., Cat. #REF33-
31AA, York, PA). Either BMSCs or MMSCs at passage
2 were seeded in these defects, culturing with 10% FBS-
DMEM for 6 weeks. The culture medium was changed
every 3 days.Six weeks later the wounded meniscus samples were
harvested and placed in pre-labeled base molds filled with
frozen section medium (Neg50; Richard-Allan Scientific;
Kalamazoo, MI). The tissue samples in base mold filled
were then quickly immersed in liquid nitrogen cold-2-
methylbutane and allowed to solidify completely. Then
the tissue blocks were placed on dry ice and subsequently
stored in the −80 °C freezer until histological analysis was
carried out.
The tissue block was cut into 10 μm thick sections
and placed on glass slides, and then these glass slides
were left over night at the room temperature to dry. The
sections were rinsed 3 times with PBS and fixed with 4%
paraformaldehyde for 30 min, then washed with PBS for
another 3 times. The chondrogenesis differentiation of
BMSCs and MMSCs on wounded rabbit meniscus was
tested by histochemical staining. The sections were
stained with alcian blue, toluidine blue, safranin O and
fast-green. All images were taken using a CCD camera
as we depicted above.
In vivo implantation experiments
Four female nude rats (10 weeks old; 200 – 250 g) were
used to test the differentiation of two kinds of MSCs
in vivo. Rats were housed individually on a 12 h : 12 h
light–dark cycle and were cared for in accordance with
the Guide to the Care and Use of Experimental Animals.
The stem cells at passage 2 with the density of 6 × 104
cells/0.1 ml were mixed with 0.5 ml of Matrigel (BD 201
Biosciences, Cat. # 354234, Bedford, MA) in a 24-well
plate and overnight cultured with DMEM-10% FBS at
37 °C and 5% CO2. In the next day, the medium was re-
moved from each well and the Matrigel with cells were
used for implantation into nude rat skin.
The nude rats were placed under general anesthesia
using ketamine hydrochloride (75 mg/kg body weight)
and xylazine hydrochloride (5 mg/kg body weight), ad-
ministrated by intramuscular injection. Wounds (1 cm
diameter/each wound) were created on the back of each
rat, and three pieces of cell-Matrigel were placed in three
distinct wounds on each side of the rat’s back. The ap-
proximate distance between two wound sites was 1.5 cm,
with a total of six cell-Matrigel composites implanted into
each rat. Each group had two rats and a total of four rats
were used for two groups. At 3 weeks after implantation,
tissue samples were harvested and frozen according to the
measure we described above.
The tissue block was cut into 10 μm thick sections,
which were then placed on glass slides and allowed to dry
overnight at room temperature. The multi-differentiation
potentials of two kinds of MSCs in vivo were tested by
immunostaining on tissue sections of nude rats after
implantation. The tissue sections were fixed with 4% para-
formaldehyde for 15 min and reacted with mouse anti-
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CA), mouse anti-osteocalcin (1:200, Abcam, Cat #13418;
Cambridge, MA), mouse anti-collagen type I (1:100,
Millipore, Cat. #MAB1340; Temecula, CA), and mouse
anti-collagen type II (1:100, Millipore, Cat. #MAB1330,
Temecula, CA) at room temperature for 2 hours. FITC-
conjugated goat anti-mouse IgM (1:500, Santa Cruz
Biotechnology, Cat. #sc-2082, Santa Cruz, CA) was used
as the secondary antibody to detect adiponectin and Cy-3
conjugated goat anti-mouse IgG (1:500, Jackson Immu-
noResearch Laboratories, Inc., Cat. #115-165-146, West
Grove, PA) was used as the secondary antibody to detect
collagen type I, collagen type II and osteocalcin at room
temperature for 2 hrs. The tissue sections were also
treated with Hoechst 33342 (Sigma, Cat. #B2261, St.
Louis, MO) to stain nuclei.
Statistical analysis
Data is presented as mean plus and minus standard de-
viation (SD). At least three replicates for each experimen-
tal condition were performed, and the presented results
are representative of these replications. One-way ana-
lysis of variance (ANOVA), followed by either Fisher’s
predicted least-square difference (PLSD) for multiple
comparisons or two tailed student t-test wherever applic-
able, were used for statistical analysis. Differences between
two groups were considered significant when the p-value
was less than 0.05.
Results
Colony formation
To characterize whether meniscus-derived cells are clo-
nogenic, we isolated and cultured single suspension from
rabbit meniscus and compared with bone marrow-derived
cells in five T25 flasks. During the initial three days in cul-
ture, these cells began to attach onto the plastic surface
and remained quiescent for approximate five days. After
8–10 days of culture, the first colony was observed in each
flask. Then large quantities of cells started rapidly dividing
to form considerable colonies at 10–15 days. Methyl violet
staining was used to discover the colony (Figure 1 A, B).
However, the number and size of cell colonies from
BMSCs and MMSCs were markedly different: colonies
formed by MMSCs were fewer in number and smaller
in size than those of BMSCs. Our data showed that
only 51.8% of colonies consisted of 50,000 cells or more in
MMSCs whereas 75.8% in BMSCs (Figure 1E).
Immunocytochemistry analysis of MMSCs and BMSCs
To confirm whether MMSCs possess the established prop-
erties of stem cells, we examined the stem cell markers
through immunochemistry staining. Over 80% positively
stained cells were found for SSEA-4, Nanog and nucleos-
temin in both MMSCs and BMSCs groups (Figure 2).Furthermore, about 86% of MMSCs and 82% of BMSCs
stained positively for STRO-1 (Figure 3E, F). In addition,
more than 85% of cells from these two groups were found
to be positively stained by CD44 and CD90 (Figure 3A-D),
while lower 3% of BMSCs were positively stained by
CD34 and only few MMSCs were found positive by CD34
(Figure 4G, H).
Multipluripotent evaluation of MMSC and BMSCs in vitro
We next examined whether MMSCs possessed the cap-
acity of differentiating into various lineages compared
to that of BMSCs. The multidifferentiation potential of
MMSCs and BMSCs towards adipogenesis, osteogenesis
and chondrogenesis were determined through histological
staining, qRT-PCR and western blot.
After 21 days in adipogenic medium, both MMSCs
and BMSCs exhibited numerous lipid droplets, an indi-
cator of adipogenesis which can be detected by Oil Red
O staining. Semiquantitative evaluation, by calculating
stained area, showed that about 24% of MMSCs and 28%
of BMSCs were differentiated into adipocytes, respectively
(Figure 5A, B). Similar to this result, on the expression
level of PPARγ, a gene marker of adipogenic lineage,
MMSCs was akin to BMSCs (Figure 4).
When cultured in osteogenic medium, BMSCs spontan-
eously began to form large aggregates in the plastic plate
at 15 days. In regard to this, we collected both types of
stem cells at 14 days, and detected the expression of
calcium using Alizarin Red S assay. More than 44% of
BMSCs were stained positively compared to 32% of
MMSCs (Figure 5C, D). Similarly, qRT-PCR analysis showed
that the expression of the osteogenic markers osteocalcin
and Runx-2 was all significantly higher in BMSCs than that
in MMSCs (Figure 4).
In regard to chondrogenesis, similarly to the previously
described observation related to the behavior of BMSCs
during osteogenic induction, MMSCs began to form ag-
gregates at 13 days, and then recruited cells continually
from circumference to generate a consolidated spherical
tissue ultimately. Consequently, the two different cell
populations were collected at 12 days and examined ex-
pression of glycosaminoglycans (GAG)-rich matrix using
Safranin O staining. About 46% positive staining in
MMSCs appeared while only 32% in BMSCs (Figure 5E, F).
Equally, MMSCs expressed higher levels of collagen
type II (2.8 folds) and Sox9 (2.3 folds) which are two
gene markers for chondrogenesis than BMSCs (Figure 4).
Western blotting was performed to quantify the level
of specific protein expression in the two groups of stem
cells. Adiponectin was expressed in both MMSCs and
BMSCs following 21 days culture in adipogenic induction
medium and there was no significant difference between
two groups. As for osteocalcin, a well-known marker of
osteogenesis, it was markedly up-regulated in BMSCs
Figure 1 The colony formation of bone marrow-derived stem cells (BMSCs) and meniscus-derived stem cells (MMSCs). A. Colonies of
BMSCs. B. Colonies of MMSCs. C. A sample colony of BMSCs. D. A sample colony of MMSCs. E. Quantitative analysis of colonies formed by BMSCs
and MMSCs. The colonies were detected by staining with Methyl violet at 15 days primary culture. Cell numbers were counted after trypsinized
from each colony respectively. Colony number of MMSCs was significantly different from that of BMSCs (*p < 0.05). (Bars: 50 μm).
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chondrogenic medium, MMSCs expressed significantly
higher levels of collagen type II which is one of the
most important indicators on chondrogenesis than
BMSCs (Figure 6).
The effect of rabbit MMSCs and BMSCs on wounded
meniscus healing
After 6 weeks culture, more than 90% of the wound area
in rabbit meniscus was healed by MMSCs treatment;
instead, by means of BMSCs treatment, 80% only washealed. Furthermore, more cartilage-related proteins were
formed in the meniscus treated by MMSCs than that
treated by BMSCs, as observed with staining using
toluidine blue (dark brown in Figure 7B), safranin O
(larger red area in Figure 7D), fast green and safranin O
(larger red area in Figure 7F) and alcian blue (extensive
green area in Figure 7H).
Immunostaining assay of cell- Matrigel composite
The differentiation capability in vivo was examined by
implanting these two kinds of MSCs into nude rats. The
Figure 2 Expression of stem cell markers for BMSCs and MMSCs. Both types of MSCs exhibited high expression of stem cell markers, SSEA-4
(A, B), Nanog (C, D), and nucleostemin (E, F), respectively. Insets show enlarged view of positive staining with three stem cell markers. There was
no great difference in the expression of these three recognized stem cell markers. (Magnification of microscopy: 20×) (Bar: 50 μm).
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MMSCs and BMSCs were subcutaneously implanted with
Matrigel into the back of nude rats, in samples implanted
with Matrigel-MSCs, greater positively for osteocalcin
was observed in the samples made of Matrigel-BMSCs
(Figure 8C) compared to those with Matrigel-MMSCs
(Figure 8D), while the samples with Matrigel-MMSCs
expressed much more collagen type II protein (Figure 8F)
than those with Matrigel-BMSCs (Figure 8E). As for ex-
pression of adipogenesis, no significant difference were
found between BMSCs and MMSCs.
Discussion
The aim of the study was to investigate if MSCs may
reside in rabbit menisci and if there is any difference be-
tween these meniscus-derived MSCs and bone marrow-derived MSCs. Towards this aim, MMSCs and BMSCs
were isolated from rabbit menisci and bone marrow, and
their differentiation potential, stem cell marker expression,
colony formation were examined. Although the basic cel-
lular architecture of rabbit meniscus has been established
previously, there is no report on stem cells isolated rabbit
menisci [16,17]. Furthermore, mesenchymal stem cells
were initially isolated from bone marrow, it has already
gained acceptance that they reside in different adult con-
nective tissues such as synovium, periosteum, adipose
tissue, and muscle [18-21].
Actually, a recent study demonstrated that a unique cell
subpopulation with the typical characteristics of mesen-
chymal stem cells resided within rabbit meniscus. These
may effectively protect the joint surface and maintained
joint space width in an experimental OA model [22].
Figure 3 Expression of MSC markers for BMSCs and MMSCs. All three MSC markers, i.e. CD 44, CD 90 and Strol-1, were strong expressed in
BMSCs (A, C and E) and MMSCs (B, D and F). Additionally, CD 34, a hematopoietic cell marker was negative stained in MMSCs (H) and lower 3%
positively stained in BMSCs (G). (Magnification of microscopy: 20×) (Bar: 50 μm)
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cells and what are the differential properties between
these meniscus-derived cells and BMSCs remain largely
undefined.
Clonogenicity is an important trait of adult stem cells
including neural, hematopoietic, tendon, and epidermal
stem cells, as well as for embryonic stem cells [19,23-26].High frequency of colony formation in MMSCs and
BMSCs denotes that large amount of mesenchymal stem
cells or progenitor cells reside in the meniscus as well as
in the bone marrow.
Our results showed that both populations expressed
high level of characteristic stem cell markers including
SSEA-4, Nanog and nucleostemin. However, there is no
Figure 5 Histochemical staining of differentiated cells and semi-quantification of the extent of cell differentiation. Both BMSCs and
MMSCs were able to differentiate into adipocytes (A, B), osteocytes (C, D), and chondrocytes (E, F), as shown by the accumulation of lipid
droplets, proteoglycans and calcium deposits on cell surfaces. However, higher extent of osteogenic differentiation in BMSCs was evidenced by
the most positive staining areas through Alizarin Red S assay. Conversely, much higher potential of chondrogenic differentiation in MMSCs was
verified by Safranin O staining. Note that each experiment was repeated three times using five different donors. (P < 0.05) (Magnification of
microscopy: 20×) (Bar: 50 μm).
Figure 4 The qRT-PCR analysis of adipogenic, osteogenic and chondrogenic marker genes. Much higher expression of chondrogenic gene
markers including collagen type II and Sox9 were observed in MMSCs group (**P < 0.01). However, BMSCs expressed much higher level of osteogenic
gene markers such as osteocalcin and Runx-2 (**P < 0.01) No great difference was found on expression of adipogenic gene marker. Note that the gene
expression levels were normalized to GAPDH, and obtained from at least three independent experiments.
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Figure 6 Representative western blots of differentiated BMSCs and MMSCs. Collagen type II, the most important indicator for chondrogenesis,
was expressed much higher in MMSCs than that in BMSCs. Meanwhile, BMSCs displayed higher expression of osteocalcin, a typical production
of osteogenesis. Note that our data were normalized to GAPDH, and obtained from at least three independent experiments. (P < 0.05).
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between BMSCs and MMSCs (P > 0.05). These findings
indicated that the stem cells isolated from rabbit menis-
cus have similar properties to those of BMSCs.
SSEA-4, a stage-specific embryonic antigen previously
thought to mark specifically human embryonic stem cells
and very early cleavage to blastocyst stage embryos, also
marks an adult mesenchymal stem cell population [27].
Nanog is only expressed in embryonic stem cells (ESCs)
and is thought to be a key factor in maintaining pluripo-
tency [28]. Nucleostemin is a kind of nucleolar protein
which is abundantly expressed while the cells are prolifer-
ating in an early, multipotential state, but it abruptly and
almost entirely disappears at the beginning of the differen-
tiation stage. It is also indicated that this type of protein
plays a role in maintaining stem cell self-renewal and
regulating the proliferation of stem cells [29,30].
Stro-1 is a surface antigen found on bone marrow mono-
nuclear cells capable of differentiating into osteogenic,
chondrogenic and adipogenic lines [31]. It is well known
that MSCs express CD44 and CD90, but lack expression
of CD34 [32]. Our results agree with the criteria to define
MSC. Taken together, the substrate-dependent expres-
sion of the above stem cell markers protein reveals that
MMSCs still remain undifferentiated stem cells and pre-
serve self-renewal capability similarly to BMSCs.
According to the suggestion by the Mesenchymal and
Tissue Stem Cell Committee of the International Society
for Cellular Therapy, another basic criteria required for
MSC is that they must possess the potential to differen-
tiate into osteoblasts, adipocytes and chondroblasts [32].
Whether in vitro or in vivo, our findings display that,similar to BMSCs, MMSCs undoubtedly exhibit their
multi-potent properties. Furthermore, MMSCs showed a
promising chondrogenic differentiation potential compared
to BMSCs. Collectively, these data suggest that both
BMSCs and MMSCs share common features of MSC
populations but display some peculiarities related to
their unique differentiating potential. There is ample evi-
dence that even partial meniscectomy greatly changes
knee biomechanics and increases the contact pressure
on the articular cartilage [33]. The overriding problem
with a meniscal tear is the limited capacity that the menis-
cus has to heal itself effectively, especially in the avascular
zone [34]. However, the inability of surgeons to repair the
damaged meniscus–both anatomically and functionally,
continues to present challenges [35].
Regarding meniscus repair, previous studies have re-
ported that transplanted MSCs from green fluorescent
protein transgenic (GFP) rats into meniscal defect could
survive and contribute to synthesis of extracellular matrix
[36]. Recently, Pabbruwe et al. described beneficial effects
on meniscal regeneration by using the stem cell/collagen-
scaffold implant [7]. Zellner et al. demonstrated that the
repair of punch defects in the avascular zone of the menis-
cus was achieved with the combination of biodegradable
composite matrices and non-precultured BMSCs [8].
Since MSCs can be easily isolated from bone marrow
and other sources, it was originally thought that after the
delivery of culture-expanded MSCs to the injured host,
they would migrate to the site of injury and directly dif-
ferentiate into the cells of an appropriate phenotype
and function, thus contributing to the repair of the injured
tissue [37].
Figure 7 Histochemical staining on wounded meniscus cultured with BMSCs or MMSCs for 6 weeks. The meniscus was cut into 10 μm
section and stained by toluidine blue (A, B), safranin O (C, D), fast green and safranin O (E, F), alcian blue (G, H). All imaging showed that
more cartilage-related proteins were detected in the meniscus treated with MMSCs than BMSCs. (P < 0.05) (Magnification of microscopy: 20×)
(Bar: 50 μm).
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could mediate robust tissue repair, but exhibited low or/and
transient engraftment into the injured tissue [38]. It has
been reported that BMSCs express cardic-specific markers,
retain the stromal phenotype, but they do not become
functional cardiomycytes in vitro [39]. Although several
studies have shown that MSCs may acquire differenti-
ated phenotype, they lack functional activity of special-
ized cells [40,41]. Moreover, BMSCs suffer from a main
drawback: they appear to have a high propensity for
cartilage hypertrophy and bone formation, and therefore
may not be ideal chondro-progenitors for the repair of
meniscus [9,10,20,42-44].Superior chondrogenic differentiation potential of
MMSCs makes this cell population be a reservoir of
stem cells which offer a promising option treating dam-
aged meniscus through cell therapy. MSCs derived from
various mesenchymal tissues contain common features,
but an increasing number of reports describe distinguish-
ing properties dependent on their origin [45,46]. MMSCs
may have an important role in repairing meniscus tear in
the future. First, homing trait of stem cells determines that
MMSCs are more prone to migrate to the meniscus de-
fect than any other stem cells [47]. Second, as meniscus-
specific stem cells, MMSCs can by default differentiate
into fibroblast-like cells or chondrocyte-like cells naturally.
Figure 8 Immunocytochemistry staining on complexes implanted Matrigel with BMSCs or MMSCs into the back of nude rats for 3 weeks.
The tissue sections were stained with anti-adiponectin (A, B), anti-osteocalcin (C, D), anti-collagen type II (E, F), respectively. It is seen that two kinds of
stem cells have multi-differentiation potential in vivo. The implantation of BMSCs resulted in more bone-like tissue formation (C, pink) than MMSCs
(D). More cartilage-like tissues were observed in MMSCs group, as shown by immunostaining for collagen type II (F, red). (P < 0.05) (Magnification of
microscopy: 20×) (Bar: 50 μm).
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control the process of differentiation into chondrogenic
cells than any other kinds of MSCs. Finally, compared to
other MSCs populations, MMSCs may adapt to the niche
of the meniscus during the long-term repairing process
due to their meniscus originated [42]. Our study showed
that (1) meniscus tissues contain cells with stem-cell
character, (2) these meniscus-derived cells possess ex-
cellent chondrogenic differentiation potential compared
to BMSCs, and (3) this specific traits distinct from BMSCs
may promote the regeneration of wounded meniscus.
A few limitations in the present study still exist. First,
rabbit meniscus is different from human on the main struc-
tural features, including cellular distribution, vascularity,and collagen structure [47]. Hence, in order to accurately
demonstrate the efficacy of MMSCs on human meniscus
repair, larger animal models are required for further studies.
Second, cells used in this study were isolated from the
whole meniscus of young rabbits (8–10 weeks old),
however, two distinct regions of meniscus have been
distinguished based on different vascularization states.
Whether there are some differences between two MMSCs
populations harvested from vascular region and avascular
region remains indeterminate. More precise isolation of
MMSCs from different regions of meniscus and differ-
ent ages of animals should be adopted in the future.
Third, this study didn’t investigat the effect of MMSCs
on wounded meniscus healing in vivo. In the future
Ding and Huang BMC Musculoskeletal Disorders  (2015) 16:65 Page 13 of 14study, we will use nanostructured scaffold to deliver
MMSCs into the wounded meniscus of large animals
and investigated aging effect on MMSCs for meniscus
repair and regeneration.
Conclusions
Our study demonstrated that both BMSCs and MMSCs
share common features of MSCs populations in colony
formation and multi-differentiation potential. Comparing
to BMSCs, MMSCs may serve as an alternative cell ther-
apy in repairing damaged meniscus due to their homing
traits and promising potential on chondrogenic differenti-
ation which conduce them to adapt to the niche inside
the meniscus. The present results indicated that the stem
cells isolated from meniscal may be used for an allogeneic
transplantation through scaffold for meniscal repair in
human.
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